148 related articles for article (PubMed ID: 7994650)
1. [Effect of BN52021 on platelet activating factor induced aggregation of psoriatic polymorphonuclear neutrophils].
Liu BJ; Zhang HT; Zheng MR
Zhonghua Yi Xue Za Zhi; 1994 Jun; 74(6):370-2, 392. PubMed ID: 7994650
[TBL] [Abstract][Full Text] [Related]
2. Aggregation of human polymorphonuclear leukocytes by endothelin: role of platelet-activating factor.
Gómez-Garre D; Guerra M; González E; López-Farré A; Riesco A; Caramelo C; Escanero J; Egido J
Eur J Pharmacol; 1992 Dec; 224(2-3):167-72. PubMed ID: 1468506
[TBL] [Abstract][Full Text] [Related]
3. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
[TBL] [Abstract][Full Text] [Related]
4. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM
J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
[TBL] [Abstract][Full Text] [Related]
5. Cell adhesion by membrane-bound paf-acether.
Ninio E; Leyravaud S; Bidault J; Jurgens P; Benveniste J
Int Immunol; 1991 Nov; 3(11):1157-63. PubMed ID: 1760410
[TBL] [Abstract][Full Text] [Related]
6. Effects of MTX and BN52021 on PAF-induced chemotaxis of PMNs and intraepidermal accumulation of inflammatory cells in guinea pigs.
Liu B; Zhang H; Li S; Chen W
Chin Med J (Engl); 1996 Jun; 109(6):467-70. PubMed ID: 9206081
[TBL] [Abstract][Full Text] [Related]
7. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha 'primes' the platelet-activating factor-induced superoxide production by human neutrophils: possible involvement of G proteins.
Paubert-Braquet M; Hosford D; Klotz P; Guilbaud J; Braquet P
J Lipid Mediat; 1990; 2 Suppl():S1-4. PubMed ID: 1966810
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes.
Földes-Filep E; Braquet P; Filep J
Biochem Biophys Res Commun; 1987 Nov; 148(3):1412-7. PubMed ID: 2825685
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
McColl SR; Krump E; Naccache PH; Poubelle PE; Braquet P; Braquet M; Borgeat P
J Immunol; 1991 Feb; 146(4):1204-11. PubMed ID: 1846895
[TBL] [Abstract][Full Text] [Related]
12. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro.
Hirafuji M; Shinoda H
Br J Pharmacol; 1991 Jun; 103(2):1333-8. PubMed ID: 1884095
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage.
Vercellotti GM; Yin HQ; Gustafson KS; Nelson RD; Jacob HS
Blood; 1988 Apr; 71(4):1100-7. PubMed ID: 2451547
[TBL] [Abstract][Full Text] [Related]
14. Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteins.
Braquet P; Hosford D; Koltz P; Guilbaud J; Paubert-Braquet M
Lipids; 1991 Dec; 26(12):1071-5. PubMed ID: 1668107
[TBL] [Abstract][Full Text] [Related]
15. [Ginkgolides antagonizing some effects of platelet-activating factor in vitro].
Dong JC; Li M; Shi ZY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):606-8. PubMed ID: 8704427
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study on antagonism of ginkgolides against effect of platelet-activating factor on lung strip of guinea pigs].
Dong JC; Li M; Wu GT
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Aug; 17(8):481-3, 502. PubMed ID: 10322836
[TBL] [Abstract][Full Text] [Related]
17. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity.
Mandi Y; Farkas G; Koltai M; Beladi I; Mencia-Huerta JM; Braquet P
Immunology; 1989 Jul; 67(3):370-4. PubMed ID: 2759659
[TBL] [Abstract][Full Text] [Related]
18. Histamine potentiates human platelet aggregation induced by platelet-activating factor.
Sipka S; Koltai M; Braquet P; Szegedi G
Int Arch Allergy Immunol; 1992; 97(1):89-92. PubMed ID: 1582704
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of platelet-activating factor- and zymosan-activated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate.
Bruijnzeel PL; Warringa RA; Kok PT
Br J Pharmacol; 1989 Aug; 97(4):1251-7. PubMed ID: 2551444
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704.
Schattner M; Parini A; Fouque F; Vargaftig BB; Touqui L
Br J Pharmacol; 1989 Apr; 96(4):759-66. PubMed ID: 2787179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
